CN111202752A
|
|
Ackermanella compositions
|
CN112075936A
|
|
Health management all-in-one
|
CN110220987A
|
|
Bile acid combines marker in preparation for predicting or diagnosing the detection reagent of diabetes or the purposes of detectable substance
|
CN109754854A
|
|
A kind of diagnosis coding and the matched method and system of diagnosis name
|
CN109709228A
|
|
Lipid combines marker in the detection reagent of preparation diagnosis diabetes or the purposes of detectable substance
|
CN108771682A
|
|
Betulinic acid promotes the application of fatty acid oxidation
|
CN108478582A
|
|
Application of the betulinic acid as aliphatic acid synthase inhibitor
|
CN108324927A
|
|
Osteocalcin prepares the purposes for the treatment of Parkinsonian drugs
|
CN108897985A
|
|
A kind of method and its application of Glycohemoglobin HbA1c genetic locus scoring
|
CN107854497A
|
|
A kind of mouse model construction method of primary hyperparathyroidism state
|
CN107625775A
|
|
A kind of antidiabetic drug is improving the application of people's intestines symbiosis Ruminococcus torques and UDCA abundance
|
CN107510697A
|
|
A kind of antidiabetic drug is blocking the application of commensal gut bacterium secondary bile acid generation
|
CN107693525A
|
|
Acarbose is delaying the application of tumor in digestive tract
|
CN107375262A
|
|
Prebiotics containing OPC and its purposes in fat and metabolic syndrome medicine
|
CN107468679A
|
|
Melbine is preparing the application in treating chromaffin cell tumor medicine
|
CN107684622A
|
|
Purposes of the mTORC1 in regulation and control islet beta cell function and conversion medicine
|
CN107545144A
|
|
pheochromocytoma branch prediction system based on molecular marker
|
CN107561283A
|
|
Applications of the bone information mark CTX in abnormal carbohydrate metabolism Occurrence forecast system
|
CN106443024A
|
|
LGR4 gene/protein for screening medicine for treating hypercholesteremia
|
CN105950771A
|
|
ARMC5 gene detection kit and mutation site
|